Dupont Pharmaceuticals Company - Ownership and Business Overview

Life ScienceCompany

Dupont Pharmaceuticals Company Ownership

Who owns Dupont Pharmaceuticals Company?

Dupont Pharmaceuticals Company is owned by Bristol-Myers Squibb. It was acquired on October 2, 2001.

Dupont Pharmaceuticals Company Business Overview

Where is Dupont Pharmaceuticals Company headquartered?

Dupont Pharmaceuticals Company is headquartered in Wilmington, Delaware.

What sector is Dupont Pharmaceuticals Company in?

Dupont Pharmaceuticals Company is a life science company.

When was Dupont Pharmaceuticals Company founded?

Dupont Pharmaceuticals Company was founded in 1991.

Life Science M&A Summary in 2001

Out of 60 sectors in the Mergr database, life science ranked 16 in number of deals in 2001. The largest life science acquisition in 2001 was ALZA - which was acquired by Johnson & Johnson for $10.5B.

Join Mergr to view all 30 acquisitions of life science companies in 2001, including 10 acquisitions by private equity firms, and 20 by strategics.

Dupont Pharmaceuticals Company

974 Centre Road,
Wilmington, Delaware 19805
United States,

DuPont Pharmaceuticals Company is a life science company that produces a variety of drugs. These include SUSTIVA, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV/AIDS; COUMADIN, a widely-used oral blood anticoagulant; and CARDIOLITE(R), a cardiovascular medical imaging agent. DuPont Pharmaceuticals Company was formed in 1991 and is based in Wilmington, Delaware.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.